Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Ginkgo Bioworks Holdings

DNA

Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings 13F Holders

DNA Stock Ownership Activity

# of activities:
1
AVG reported price*:
$9.96
Current price*:
-25.60%($7.41)
1 value investing guru has made changes to the Ginkgo Bioworks Holdings (DNA) position according to the gurus' 2021 Q2 SEC quarterly report(s). DNA has been bought (as a new position) by 1 guru(s)

Which gurus or hedge funds bought DNA in 2021 Q2?

According to the 2021 Q2 SEC filing(s) Ginkgo Bioworks Holdings (DNA) has been bought by David Einhorn - Greenlight Capital (new buy).
To see more about who is investing in Ginkgo Bioworks Holdings (DNA), please go to the DNA ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.